The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2016

Filed:

Apr. 30, 2014
Applicant:

Aprofol Ag, Appenzell Steinegg, CH;

Inventor:

Martin Ulmann, Dachsen, CH;

Assignee:

APROFOL AG, Appenzell Steinegg, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 9/08 (2006.01); A61K 47/18 (2006.01); A61K 47/20 (2006.01); A61K 47/12 (2006.01); A61K 47/24 (2006.01);
U.S. Cl.
CPC ...
A61K 9/08 (2013.01); A61K 31/519 (2013.01); A61K 47/12 (2013.01); A61K 47/18 (2013.01); A61K 47/20 (2013.01); A61K 47/24 (2013.01);
Abstract

The administration of levoleucovorin is useful as an antidote to drugs which act as folic acid antagonists and in combination chemotherapy with 5-FU. The most often used calcium salt of levoleucovorin has a limited solubility in water and forms almost insoluble degradation products. Therefore aqueous solutions are unstable and precipitates are resulting. Precipitates in injectable products present an unacceptable safety risk to patients. Stable high strength pharmaceutical aqueous compositions containing calcium salts, magnesium or zinc salts of levoleucovorin and one or more of the compounds sodium gluconate, potassium gluconate, glycerophosphate disodium salt or glycerophosphate dipotassium salt are disclosed.


Find Patent Forward Citations

Loading…